News

Grant Brown, Senior Vice President and Chief Financial Officer of Qorvo, Inc. (NASDAQ:QRVO), filed a Form 4 on August 18, 2026, disclosing the sale of 5,179 shares of common stock on August 17, 2026.

A Form 4 filed with the SEC on August 18, 2026 discloses that Philip Chesley, Senior Vice President of High Performance Analog at Qorvo, Inc. (NASDAQ:QRVO), sold 5,487 shares of common stock on August 17, 2026.

A statement of changes in beneficial ownership was filed on August 18, 2026, disclosing that Brent Pfeiffenberger, President and CEO of Century Therapeutics, Inc., had 31,172 shares of common stock withheld by the issuer on August 14, 2026, to satisfy tax withholding obligations connected …

A Form 4 filed with the SEC on August 18, 2026 discloses that Todd G. Schwartz, Chief Executive Officer and Director of OppFi Inc. (NYSE:OPFI), purchased 3,500 shares of Class A Common Stock on August 17, 2026 through the TGS Revocable Trust.

Frank Stokes, Chief Financial Officer of Castle Biosciences Inc., filed a Form 4 with the SEC on August 18, 2026, disclosing the sale of 24,908 shares of common stock on August 14, 2026.

Director William P. Scully filed a Form 4 with the SEC on August 18, 2026, reporting two gift transactions involving ordinary shares of Prothena Corp Public Ltd Co, traded on NASDAQ:PRTA.

Kevin Hochman, President and CEO of Brinker International, Inc. (NYSE:EAT), filed a Form 4 on August 18, 2026, reporting the sale of 40,000 shares of common stock on August 17, 2026.